Breast Imaging Market Status, Top Emerging Trends, Growth and Business Opportunities 2032

As per the report published by The Brainy Insights, the global breast imaging market is expected to grow from USD 2.74 billion in 2020 to USD 6.36 billion by 2028, at a CAGR of 11.1% during the forecast period 2021-2028. The North America region emerged as the largest market for the breast imaging market and valued at USD 1.09 billion in 2020. Due to the presence of several technological and pharmaceutical players in countries like Canada and the U.S., North America is projected to dominate in the global breast imaging market on geographical front. On the other hand, the Asia Pacific region is expected to grow at the highest CAGR of 11.8% over the forecast period. This is mainly due to increasing awareness regarding breast cancer, improving healthcare infrastructure, and rising government support in countries such as China and India. 

Get an Inside Scoop of Study, Request now for Sample Study @ https://www.thebrainyinsights.com/enquiry/sample-request/12500

Breast Imaging Market by Technology (Ionizing Breast Imaging, Non-ionizing Breast Imaging), Type (Mammography, Breast Ultrasound, Breast MRI, Biomarkers, Positron Emission Mammography, Image-Guided Breast Biopsy), End User, Regions, and Global Forecast 2021-2028

Some of the major companies in the global breast imaging market are Hologic, Inc., GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujifilm Holdings Corporation, Aurora Imaging Technology, Inc., Canon Inc., CMR Naviscan Corporation, Delphinus Medical Technologies, Inc., Dilon Technologies, Inc., KUB Technologies Inc. (Kubtec), Micrima Limited, Planmed Oy, SonoCiné, Inc., and SuperSonic Imagine among others. The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global breast imaging industry. For instance, in October 2018, GE Healthcare announced the introduction of Invenia Automated Breast Ultrasound (ABUS) 2.0 for dense breast imaging, the only FDA-approved ultrasound supplemental breast screening technology, specifically designed for detecting cancer in dense breast tissue.

Check Index of Research Study @ https://www.thebrainyinsights.com/report/breast-imaging-market-12500

The technology segment is divided into ionizing breast imaging and non-ionizing breast imaging. The non-ionizing breast imaging segment is anticipated to grow at the highest CAGR of 11.5% over the forecast period. It has a wide range of benefits such as greater generation of anatomical details for diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewer

false positives, driving the demand for this segment. The type segment includes mammography, breast ultrasound, breast MRI, biomarkers, positron emission mammography, image-guided breast biopsy, and others. Mammography accounted for the largest market share of 45.8% in 2020. Mammography is the undisputed current modality of choice and used as the primary screening tool for breast cancer. The end-user segment includes hospitals and diagnostic centres. The hospital segment dominated the market and held a market share of 67.84% in 2020. This is mainly due to higher purchasing power, well-equipped operating & diagnostic rooms, presence of highly skilled healthcare professionals, easy accessibility, and better health coverage for hospital-based healthcare services from various private and group insurance plans.

Enquire for customization in Report @ https://www.thebrainyinsights.com/enquiry/request-customization/12500

Global breast imaging market is witnessing a rapid growth owing to increasing awareness about breast cancer across the globe. In addition to this, increasing government funding for the treatment of breast-related diseases, further boosting the growth of the market. However, the high cost of breast imaging technology and the side effects of radiation exposure is anticipated to hamper market growth.

About The Brainy Insights:
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirement whether they are looking to expand or planning to launch a new product in the global market.

Contact Us
Avinash D
Head of Business Development
Phone: +1-315-215-1633
Email: sales@thebrainyinsights.com
Web: http://www.thebrainyinsights.com

This release was published on openPR.